HPSE and plasma cell myeloma: EV biogenesis pathways are known to retain heparanase on the surface of released EVs, and upon exposure to ECM, heparanase degrades their heparan sulfate components and liberates associated signaling molecules, as demonstrated in exosomes derived from myeloma, lymphoblastoid and breast cancer cell lines [36,37,38].